Adalimumab, also known as Xumilor, is a relatively expensive drug that costs about$3,000 a pop and is an effective drug for the treatment of rheumatoid arthritis and ankylosing spondylitis. The main effect is to improve the symptoms of rheumatoid arthritis and ankylosing spondylitis, and the effect of the drug is relatively long-lasting and strong, and the drug is relatively safe and has relatively few side effects, so it is rheumatoid arthritis and ankylosing spondylitis patients. The drug is relatively safe and has relatively few side effects, so it is the drug of choice for patients with rheumatoid arthritis and ankylosing spondylitis, and needs to be observed more strictly after use to prevent other adverse reactions to the drug.